Tylenol faces scrutiny over pregnancy use and autism links, despite scientific bodies finding no firm evidence. While ...

US consumer health company Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

A £30 billion takeover shakes up the consumer health sector as Kimberly-Clark, the maker of Huggies nappies, prepares to ...

One of the biggest mergers of the year, worth $49 billion, comes just weeks after the Trump administration linked the common ...

Manufacturer has indicated some supply will be available in December, though there will be constraints because of backorders ...

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

Canadian pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while ...

Pharmacists say a shortage of medications that contain oxycodone is expected to continue into the new year, while supply of ...

On Monday, those findings became clear when Kleenex and Huggies owner Kimberly-Clark Corp. announced it is acquiring Kenvue ...